Theresa Tse
Chairman presso SINO BIOPHARMACEUTICAL LIMITED
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Attualmente, Theresa Tse è presidente di Sino Biopharmaceutical Ltd. Fa anche parte del consiglio di amministrazione di altre 5 società. La signora Tse si è laureata presso la Wharton School dell'Università della Pennsylvania.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
23/04/2024 | 6 000 000 ( 0.03% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Theresa Tse
Società | Posizione | Inizio |
---|---|---|
SINO BIOPHARMACEUTICAL LIMITED | Chairman | 30/06/2015 |
KAROLINSKA DEVELOPMENT AB | Director/Board Member | 28/11/2017 |
Golden Sword Ventures Ltd. | Director/Board Member | - |
Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. | Director/Board Member | - |
Sino Biopharmaceutical (Beijing) Ltd.
Sino Biopharmaceutical (Beijing) Ltd. Miscellaneous Commercial ServicesCommercial Services Sino Biopharmaceutical (Beijing) Ltd. is an investment holding company. Its sole asset is its 33.6% interest in Beijing Tide Pharmaceutical Co., Ltd., a pharmaceutical company established in China with limited liability, which develops, manufactures, and market pharmaceutical products. Sino Biopharmaceutical (Beijing) was founded on December 31, 2007 and is headquartered in Hong Kong. | Director/Board Member | - |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Director/Board Member | - |
invoX Pharma Ltd.
invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The private company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Director/Board Member | - |
Chia Tai Life Technology Ltd. | Director/Board Member | - |
Yun On Investment Holding Ltd. | Director/Board Member | - |
░░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Precedenti posizioni note di Theresa Tse
Società | Posizione | Fine |
---|---|---|
░░░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Formazione di Theresa Tse
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
TIANJIN BINHAI TEDA LOGISTICS (GROUP) CORPORATION LIMITED | Transportation |
SINO BIOPHARMACEUTICAL LIMITED | Health Technology |
KAROLINSKA DEVELOPMENT AB | Finance |
Aziende private | 10 |
---|---|
Beijing Tide Pharmaceutical Co., Ltd.
Beijing Tide Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Beijing Tide Pharmaceutical Co., Ltd. engages in research, development, manufacturing and sale of pharmaceutical products. The firm's products include kaifen flurbiprofen axetil injection, kaishi alprostadil injection, kaina beraprost sodium tablet and deyou pronase granules. The company was founded in May 1995 and is headquartered in Beijing, China. | Commercial Services |
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., Chia Tai Tianqing Pharmaceutical Group Co., Ltd. is an innovative pharmaceutical group enterprise based in Lianyungang, China. Chia Tai Tianqing has six major product groups, including liver disease, anti-tumor, respiratory, infection, endocrine, and cardiovascular and cerebrovascular. The Chinese company invests heavily in innovative drug research and has high-level R & D platforms such as the national enterprise technology center. Chia Tai Tianqing is preparing for a number of products to enter the international market and actively undertakes corporate social responsibilities. The private company was founded in 1969, and the CEO is Kang Xin Yu. | Health Technology |
Chia Tai-Tianqing Pharmaceutical Holdings Co., Ltd. | |
Golden Sword Ventures Ltd. | |
invoX Pharma Ltd.
invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Sino Biopharmaceutical Ltd., invoX Pharma Ltd. is a British biopharmaceutical company. The private company is based in Kingston-upon-Thames, UK. The company was founded in 2021. Benjamin Toogood has been the CEO of the company since 2023. | Health Technology |
Beijing Chia Tai Charity Foundation | |
Chia Tai Life Technology Ltd. | |
Yun On Investment Holding Ltd. | |
Sino Biopharmaceutical (Beijing) Ltd.
Sino Biopharmaceutical (Beijing) Ltd. Miscellaneous Commercial ServicesCommercial Services Sino Biopharmaceutical (Beijing) Ltd. is an investment holding company. Its sole asset is its 33.6% interest in Beijing Tide Pharmaceutical Co., Ltd., a pharmaceutical company established in China with limited liability, which develops, manufactures, and market pharmaceutical products. Sino Biopharmaceutical (Beijing) was founded on December 31, 2007 and is headquartered in Hong Kong. | Commercial Services |
France Investment (China 1) Group Ltd.
France Investment (China 1) Group Ltd. Financial ConglomeratesFinance France Investment (China 1) Group Ltd. operates as an investment holding company. The company is headquartered in Hongkong. | Finance |
- Borsa valori
- Insiders
- Theresa Tse